[HTML][HTML] Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide
Around 60% of people living with cancer are aged 65 years or older. Older cancer patients
face a unique set of age-associated changes, comorbidities and circumstances that impact …
face a unique set of age-associated changes, comorbidities and circumstances that impact …
[HTML][HTML] ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours …
The development of guidelines recommendations is one of the core activities of the
European Society for Medical Oncology (ESMO) and European Society of Gynaecologial …
European Society for Medical Oncology (ESMO) and European Society of Gynaecologial …
Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the PROSPECT trial (Alliance N1048)
E Basch, AC Dueck, SA Mitchell, H Mamon… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE The standard of care for locally advanced rectal cancer in North America is
neoadjuvant pelvic chemoradiation with fluorouracil (5FUCRT). Neoadjuvant chemotherapy …
neoadjuvant pelvic chemoradiation with fluorouracil (5FUCRT). Neoadjuvant chemotherapy …
Revisiting the dose constraints for head and neck OARs in the current era of IMRT
Head and neck cancer poses a particular challenge in radiation therapy, whilst being an
effective treatment modality it requires very high doses of radiation to provide effective …
effective treatment modality it requires very high doses of radiation to provide effective …
Composite grading algorithm for the national cancer institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
Background: The Patient-Reported Outcomes version of the Common Terminology Criteria
for Adverse Events is an item library designed for eliciting patient-reported adverse events in …
for Adverse Events is an item library designed for eliciting patient-reported adverse events in …
Lack of concordance in symptomatic adverse event reporting by children, clinicians, and caregivers: implications for cancer clinical trials
PURPOSE To examine concordance in symptomatic adverse event (AE) grading using the
Common Terminology Criteria for Adverse Events (CTCAE 4.0) for clinicians and its patient …
Common Terminology Criteria for Adverse Events (CTCAE 4.0) for clinicians and its patient …
Patient‐reported toxicities during chemotherapy regimens in current clinical practice for early breast cancer
KA Nyrop, AM Deal, SS Shachar, E Basch… - The …, 2019 - academic.oup.com
Background This study explores the incidence of patient‐reported major toxicity—symptoms
rated “moderate,”“severe,” or “very severe”—for chemotherapy regimens commonly used in …
rated “moderate,”“severe,” or “very severe”—for chemotherapy regimens commonly used in …
Efficiency of electronic health record assessment of patient-reported outcomes after cancer immunotherapy: a randomized clinical trial
L Zhang, X Zhang, L Shen, D Zhu, S Ma… - JAMA network …, 2022 - jamanetwork.com
Importance Cancer immunotherapy causes a wide range of immune-related adverse events
(irAEs) that require close and timely follow-up. Objectives To compare the efficiency …
(irAEs) that require close and timely follow-up. Objectives To compare the efficiency …
Feasibility of implementing the patient-reported outcomes version of the common terminology criteria for adverse events in a multicenter trial: NCCTG N1048
E Basch, AC Dueck, LJ Rogak, SA Mitchell… - Journal of Clinical …, 2018 - ascopubs.org
Purpose The US National Cancer Institute (NCI) Patient-Reported Outcomes version of the
Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed to enable …
Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed to enable …
Effectiveness of a smartphone application as a support tool for patients undergoing breast cancer chemotherapy: a randomized controlled trial
S Handa, H Okuyama, H Yamamoto, S Nakamura… - Clinical breast …, 2020 - Elsevier
Background Outpatients undergoing cancer chemotherapy experience anxiety related to
adverse drug reactions that they can experience at home. We developed a breast cancer …
adverse drug reactions that they can experience at home. We developed a breast cancer …